MYC and neoplasm: Prensner et al. showed that prostate cell proliferation promoted by PCAT-1 was c-MYC dependent; in turn, PCAT-1 increased MYC 3′UTR activity and exerted a protective effect on tumor cells by abolishing miR-34a-dependent targeting of c-MYC [50–52].